Forbion and HV Capital led a $20m Series A funding round in PACT.

Forbion, a global life sciences venture capital, and HV Capital, an early-stage and growth investors in Europe, led a $20m Series A funding round in PACT, a biomaterials innovator. “As a Cambridge-trained scientist, developing them in the lab isn’t the hard part; the real challenge lies in scaling them to meet the exacting standards of the textile industry. From our very first investment, I realised that industrialisation and scalability are essential to making materials innovation truly succeed. That’s why we see existing manufacturers as key partners in this journey,” Yudí Ding, PACT Co-Founder and CEO.